文献速递糖尿病甲状腺疾病

促甲状腺激素和甲状腺激素与糖尿病发病率:巴西成人健康纵向研究(ELSA-BRASIL)的前瞻性结果

Thyroid-Stimulating Hormone and Thyroid Hormones and Incidence of Diabetes: Prospective Results of the Brazilian Longitudinal Study of Adult Health (ELSA-BRASIL).
PubMed 文献 · Thyroid · 2022-05-24

ELSA-Brasil 队列纳入7948名35-74岁基线(2008-2010)参与者,随访8.2年(2017-2019),评估TSH、fT4、fT3及fT3:fT4比值与糖尿病发病风险。结果显示,连续变量中fT4每增加1单位糖尿病风险降低(RR 0.94 [CI 0.91-0.99]),fT3:fT4比值每增加1单位风险升高(RR 1.37 [CI 1.15-1.63]);超重或肥胖者最低五分位fT4组风险略高(RR 1.04 [CI 1.01-1.07]),第一五分位fT3:fT4比值组风险略低(RR 0.95 [CI 0.93-0.98])。作者认为fT4、fT3水平及转化率可能是糖尿病发病的额外风险因素,尤其超重或肥胖者,但需未来研究证实。

要点

  • 在甲功正常及亚临床甲状腺功能异常者中,TSH、fT4、fT3及fT3:fT4比值五分位与糖尿病发病无显著关联。
  • 连续变量分析中,fT4每增加1单位糖尿病风险降低(RR 0.94 [CI 0.91-0.99]),fT3:fT4比值每增加1单位风险升高(RR 1.37 [CI 1.15-1.63])。
  • 超重或肥胖者中,fT4最低五分位糖尿病风险略高(RR 1.04 [CI 1.01-1.07]),fT3:fT4比值第一五分位风险略低(RR 0.95 [CI 0.93-0.98])。

核心结论

  • 这些发现提示fT4、fT3水平及转化率可能是糖尿病发病的额外风险因素,尤其在超重或肥胖者中,但需未来研究证实。

研究设计与样本

  • ELSA-Brasil为高度混合队列研究,基线2008-2010年纳入35-74岁参与者,随访8.2年(2017-2019)。
  • 共纳入7948名参与者(平均年龄50.2岁[标准差8.6],54.4%女性):7177名甲功正常、726名亚临床甲状腺功能减退、45名亚临床甲状腺功能亢进。
  • 采用泊松回归(稳健方差)计算相对风险(RR)及95%CI,多变量调整社会人口学和心血管危险因素,以第三五分位为参照,并分析连续变量。

主要发现

  • 糖尿病发病率为14.8%。
  • TSH、fT4、fT3及fT3:fT4比值五分位与糖尿病发病无显著关联。
  • 连续变量分析中,fT4每增加1单位糖尿病风险降低(RR 0.94 [CI 0.91-0.99]),fT3:fT4比值每增加1单位糖尿病风险升高(RR 1.37 [CI 1.15-1.63])。
  • fT3每增加1单位与糖尿病风险升高相关,但多变量调整后无显著性。
  • 按体重指数分层,超重或肥胖者中fT4最低五分位糖尿病风险略高(RR 1.04 [CI 1.01-1.07]),fT3:fT4比值第一五分位与糖尿病发病呈反向关联(RR 0.95 [CI 0.93-0.98]);连续变量分析结果类似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者结论指出这些发现需在未來研究中证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: There are conflicting data regarding the association of thyroid function with incident diabetes. We prospectively investigated thyrotropin (TSH), free thyroxine (fT4), free triiodothyronine (fT3), and its conversion ratio (fT3:fT4) with the risk of developing diabetes in euthyroid subjects and those with subclinical thyroid dysfunction. Our hypothesis is that this relationship is a U-shaped curve since both subclinical thyroid diseases may be associated with diabetes. Methods: ELSA-Brasil is a highly admixed cohort study of 35-74 years old at baseline (2008-2010). Levels of TSH, fT4, fT3, and fT3:fT4 ratio were evaluated at baseline and incident diabetes was estimated over an 8.2-year follow-up (2017-2019). Diabetes was identified based on medical diagnosis, prescriptions, and laboratory tests. The risk of diabetes was evaluated according to quintiles of TSH, fT4, fT3, and fT3:fT4 ratio using Poisson regression with robust variance presented as relative risk (RR) with confidence interval [CI] of 95% after multivariable adjustment for sociodemographic and cardiovascular risk factors (reference third quintile), and as continuous variables. Results: We included 7948 participants (mean age, 50.2 [standard deviation 8.6] years; 54.4% female): 7177 euthyroid, 726 with subclinical hypothyroidism, and 45 with subclinical hyperthyroidism. Incidence of diabetes was 14.8%. No association was found for TSH, fT4, fT3, and fT3:fT4 ratio quintiles with incident diabetes. Using continuous variables, the increase of 1-unit (1-U) of fT4 decreased the risk of diabetes (RR 0.94 [CI 0.91-0.99]), while the increase of 1-U of the fT3:fT4 ratio increased the diabetes risk (RR 1.37 [CI 1.15-1.63]). The increase of 1-U of fT3 was associated with an increased risk of diabetes, but without significance after multivariable adjustment. In body mass index-stratified analysis, people with overweight or obesity presented a modest significantly higher risk of diabetes in the lowest quintile of fT4 (RR 1.04 [CI 1.01-1.07]) and an inverse association with incident diabetes in the first quintile of fT3:fT4 ratio (RR, 0.95 [CI 0.93-0.98]). The analyses using continuous variables presented similar findings. Conclusion: These findings suggest that fT4 and fT3 levels and the conversion rate might be additional risk factors associated with incident diabetes, especially in the presence of overweight or obesity. However, they need to be confirmed in future studies. (ClinicalTrials.gov Identifier: NCT02320461).

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Birck MG, Almeida-Pititto B, Janovsky CCPS, et al. Thyroid-Stimulating Hormone and Thyroid Hormones and Incidence of Diabetes: Prospective Results of the Brazilian Longitudinal Study of Adult Health (ELSA-BRASIL). Thyroid. 2022. PMID: 35473396. doi:10.1089/thy.2021.0533

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。